Make defeating cancer a “national priority” says US progress reportBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d6075 (Published 23 September 2011) Cite this as: BMJ 2011;343:d6075
- Susan Mayor
The progress made in understanding the biology of cancer over the past 40 years, particularly in genetics and personalised medicine, will fail to translate into improvements in patient survival unless the US government continues to invest in publicly funded research, leading scientists and doctors argue in a report.
The American Association for Cancer Research’s report is calling on Congress to provide the National Institutes of Health (NIH) and the National Cancer Institute (NCI) with sustained budget increases of at least 5% above the biomedical inflation rate, which measures cost increases in health and related expenditure and is currently 14% per year.
The association’s first report on progress in cancer research tracks scientific and clinical developments over the past 40 years since the National Cancer Act was introduced. The US legislation signalled the start of major investment in publicly funded …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial